Tag: Pharmacy
FDA Says Pharmacies Can Still Compound Generic Makena
Pharmacies can continue to compound generic hydroxyprogesterone caproate for reducing the risk for preterm delivery despite warnings from KV Pharmaceutical — which sells a costly, branded version of the drug — not to do so, the US Food and Drug Administration (FDA) announced today. On February 3, the FDA approved KV Pharmaceutical’s Makena, an injectable form of hydroxyprogesterone…
Read More